Tetrabutylammonium Fluoride → 2-[5-(6-Chloro-2-methylpyridin-3-yl)-1,2,4-oxadiazol-3-yl]ethanol
反応式
[Si]([O:18][CH2:19][CH2:20][C:21]1[N:25]=[C:24]([C:26]2[C:27]([CH3:33])=[N:28][C:29]([Cl:32])=[CH:30][CH:31]=2)[O:23][N:22]=1)(C(C)(C)C)(C1C=CC=CC=1)C1C=CC=CC=1.[F-].C([N+](CCCC)(CCCC)CCCC)CCC>O1CCCC1>[Cl:32][C:29]1[N:28]=[C:27]([CH3:33])[C:26]([C:24]2[O:23][N:22]=[C:21]([CH2:20][CH2:19][OH:18])[N:25]=2)=[CH:31][CH:30]=1参加物
4
反応条件
- 温度
- 50 °C
実験手順
3-[3-(2-{[tert-Butyl(diphenyl)silyl]oxy}ethyl)-1,2,4-oxadiazol-5-yl]-6-chloro-2-methylpyridine (210 mg, 0.44 mmol) was taken up in tetrahydrofuran (2.2 ml) and tetrabutylammonium fluoride (0.44 ml of 1.0 M in THF, 0.44 mmol) was added. The solution was heated to 50° C. for 2 hours, cooled to room temperature, concentrated under reduced pressure, and directly purified via silica gel chromatography (0-100% ethyl acetate in hexane) to afford the title compound.
後処理
- temperaturecooled to room temperature
- concentrationconcentrated under reduced pressure
- customdirectly purified via silica gel chromatography (0-100% ethyl acetate in hexane)
出典と根拠
- ORDレコード
- ord-25a6fe6f4beb40d88a9b5250aee69186
- 出典データセット
- uspto-grants-2013_02
- 特許番号
- US08367706B2
反応ノート
読み込み中…